Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 25, 2024

BUY
$2.07 - $2.83 $155 - $212
75 New
75 $0
Q3 2023

Nov 01, 2023

SELL
$2.51 - $3.55 $9,036 - $12,780
-3,600 Reduced 59.06%
2,496 $6,000
Q2 2023

Aug 04, 2023

BUY
$2.12 - $4.47 $12,923 - $27,249
6,096 New
6,096 $21,000
Q4 2022

Feb 02, 2023

SELL
$5.88 - $12.03 $28,171 - $57,635
-4,791 Reduced 11.09%
38,427 $462,000
Q3 2022

Nov 04, 2022

BUY
$4.6 - $9.91 $105,132 - $226,493
22,855 Added 112.24%
43,218 $280,000
Q2 2022

Aug 03, 2022

BUY
$3.72 - $9.0 $75,750 - $183,267
20,363 New
20,363 $93,000
Q1 2022

May 02, 2022

SELL
$8.19 - $13.89 $56,756 - $96,257
-6,930 Closed
0 $0
Q4 2021

Feb 23, 2022

BUY
$12.98 - $29.75 $89,951 - $206,167
6,930 New
6,930 $98,000
Q4 2020

Feb 02, 2021

SELL
$2.48 - $4.64 $59,827 - $111,935
-24,124 Closed
0 $0
Q3 2020

Oct 14, 2020

BUY
$2.58 - $4.16 $62,239 - $100,355
24,124 New
24,124 $62,000
Q1 2020

Apr 29, 2020

SELL
$2.6 - $5.5 $15,870 - $33,572
-6,104 Closed
0 $0
Q4 2019

Feb 05, 2020

BUY
$2.43 - $5.74 $14,832 - $35,036
6,104 New
6,104 $31,000
Q3 2019

Oct 15, 2019

SELL
$2.88 - $3.96 $5,112 - $7,029
-1,775 Closed
0 $0
Q2 2019

Jul 26, 2019

BUY
$2.88 - $4.36 $5,112 - $7,739
1,775 New
1,775 $6,000
Q1 2019

Apr 18, 2019

SELL
$2.95 - $3.64 $3,053 - $3,767
-1,035 Closed
0 $0
Q4 2018

Jan 16, 2019

BUY
$3.0 - $4.94 $1,464 - $2,410
488 Added 89.21%
1,035 $3,000
Q3 2018

Oct 23, 2018

BUY
$4.64 - $7.11 $2,538 - $3,889
547 New
547 $2,000

Others Institutions Holding ORMP

About ORAMED PHARMACEUTICALS INC.


  • Ticker ORMP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 38,827,100
  • Market Cap $92.4M
  • Description
  • Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions for the treatment of diabetes and for the use of orally ingestible capsules or pills for delivery of polypeptides. Its proprietary flagship product is the ORMD-0801, an orally ingestible insulin capsule, which completed phase II clinical trials for th...
More about ORMP
Track This Portfolio

Track Simplex Trading, LLC Portfolio

Follow Simplex Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Simplex Trading, LLC with notifications on news.